Golden rules for registrars
Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more
The EPP, which began in 2002, runs self-management courses for patients to help them manage their conditions.
Last year's primary care White Paper promised to triple the scheme's expenditure.
This month the DoH released ‘internal evaluation data' about the EPP's effectiveness.
The full research was unavailable from the DoH, but a spokesman said that data from approximately 1,000 EPP participants showed patients attended 7 per cent fewer GP consultations and had 16 per cent fewer attendances at A&E and 10 per cent fewer outpatient visits.
A total of 38 per cent felt that symptoms including depression were less severe up to six months after completing a course.
However experts from the National Primary Care Research and Development Centre at Manchester University believe that the programme will fail to deliver the expected results.
Professor Anne Rogers, who led the rival Manchester research, which was DoH funded, said: 'There was no reduction in the number of healthcare visits as a result of this scheme.'
She suggested that data used by the DoH was flawed.
Quick search - use * for an abbreviated search, eg nico*
Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more
Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more
Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more
Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more
Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more
By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more
Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more
Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more
Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more
Comments
Only registered users may comment. Log in now or register for a free account.